CVE-2025-15066: Innorix WP · Path Traversal
Affects Innorix WPSource CVE Database V5
Not known to be exploited · CVSS 6.9 Medium.
Data as of 26 Oct 2026, 06:26 UTC
- EPSS
- 0.1% chance of exploitation in 30 days – higher than 5% of CVEsExploit Prediction Scoring System: the likelihood attackers will use this flaw soon.
CVSS:4.0/AV:L/AC:L/AT:N/PR:N/UI:N/VC:H/VI:N/VA:N/SC:N/SI:N/SA:NExploitation evidence
Disclosed: evidence found.
CVE published 29 Dec 2025
Detectable: no evidence on record.
No public nuclei template indexed
Weaponised: no evidence on record.
No public exploit code indexed in Metasploit or Exploit-DB
Exploited in the wildExploited: no evidence on record.
Not in CISA KEV and no source reports exploitation
Observed by OffSeq MirageSeen by Mirage: no evidence on record.
No attack traffic recorded by OffSeq Mirage sensors
A missing step is not evidence of safety. Sources: cve.org (opens in a new tab), the Metasploit, Exploit-DB and nuclei-templates index as of 2026-10-26.
What to do
Affected software
| Product | Affected | Fixed in |
|---|---|---|
| Innorix Innorix WP | Affected
| Fixed in– |
AI-suggested
1. Immediately verify if the 'exam' directory exists under the Innorix WP installation path; if it is not required, remove or rename it to prevent exploitation. 2. Implement strict input validation and sanitization on all pathname inputs within Innorix WP to ensure traversal sequences (e.g., '../') are blocked or properly handled. 3. Restrict local access to systems running Innorix WP to trusted users only, employing strong access controls and monitoring. 4. Monitor file system access logs for unusual or unauthorized attempts to access directories outside the intended scope, especially targeting the 'exam' directory or parent directories. 5. If possible, isolate Innorix WP installations in segmented network zones to limit lateral movement in case of compromise. 6. Engage with Innorix vendor support to obtain patches or official guidance once available. 7. Conduct regular security audits and penetration testing focusing on path traversal and authorization bypass vulnerabilities. 8. Educate system administrators and users about the risks of local privilege escalation and path traversal attacks to enhance detection and response capabilities.
Description
Improper Limitation of a Pathname to a Restricted Directory ('Path Traversal'), Missing Authorization vulnerability in Innorix WP allows Path Traversal.This issue affects Innorix WP from All versions If the "exam" directory exists under the directory where the product is installed (ex: innorix/exam)